A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.23878/fullpdf
Reference20 articles.
1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer.,2001
2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med.,2008
3. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer;Philip;J Clin Oncol.,2005
4. Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma;Zhu;J Clin Oncol.,2006
5. SobinH,WittekindCH, eds. TMN Classification of Malignant Tumors. New York, NY: Wiley-Liss; 1997.
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Direct abdominal vein thrombus imaging (DATI): a contrast-free black-blood MR technique for the diagnosis of abdominal vein thrombosis;Abdominal Radiology;2024-05-23
2. Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma;Cancer Medicine;2023-05-10
3. Tumour Staging for Hepatocellular Carcinoma;Atlas of Hepatocellular Carcinoma Pathology;2022
4. A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus;Hepatobiliary Surgery and Nutrition;2021-12
5. Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders;Hepatology Communications;2021-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3